BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Russell K, Gillanders LK, Orr DW, Plank LD. Dietary copper restriction in Wilson's disease. Eur J Clin Nutr 2018;72:326-31. [PMID: 29235558 DOI: 10.1038/s41430-017-0002-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Wei N, Dai Z. The Role of Nutrition in Osteoarthritis. Clinics in Geriatric Medicine 2022;38:303-22. [DOI: 10.1016/j.cger.2021.11.006] [Reference Citation Analysis]
2 Członkowska A, Litwin T, Dusek P, Ferenci P, Lutsenko S, Medici V, Rybakowski JK, Weiss KH, Schilsky ML. Wilson disease. Nat Rev Dis Primers 2018;4:21. [PMID: 30190489 DOI: 10.1038/s41572-018-0018-3] [Cited by in Crossref: 134] [Cited by in F6Publishing: 120] [Article Influence: 33.5] [Reference Citation Analysis]
3 Puri P, Dhiman RK, Taneja S, Tandon P, Merli M, Anand AC, Arora A, Acharya SK, Benjamin J, Chawla YK, Dadhich S, Duseja A, Eapan CE, Goel A, Kalra N, Kapoor D, Kumar A, Madan K, Nagral A, Pandey G, Rao PN, Saigal S, Saraf N, Saraswat VA, Saraya A, Sarin SK, Sharma P, Shalimar, Shukla A, Sidhu SS, Singh N, Singh SP, Srivastava A, Wadhawan M. Nutrition in Chronic Liver Disease: Consensus Statement of the Indian National Association for Study of the Liver. J Clin Exp Hepatol 2021;11:97-143. [PMID: 33679050 DOI: 10.1016/j.jceh.2020.09.003] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Zhang Y, Dai M, Liu K, Peng C, Du Y, Chang Q, Ali I, Naz I, Saroj DP. Appraisal of Cu( ii ) adsorption by graphene oxide and its modelling via artificial neural network. RSC Adv 2019;9:30240-8. [DOI: 10.1039/c9ra06079k] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Lynch EN, Campani C, Innocenti T, Dragoni G, Forte P, Galli A. Practical insights into chronic management of hepatic Wilson’s disease. World J Clin Cases 2022; 10(14): 4334-4347 [DOI: 10.12998/wjcc.v10.i14.4334] [Reference Citation Analysis]
6 Kasztelan-Szczerbinska B, Cichoz-Lach H. Wilson's Disease: An Update on the Diagnostic Workup and Management. J Clin Med 2021;10:5097. [PMID: 34768617 DOI: 10.3390/jcm10215097] [Reference Citation Analysis]
7 Mulligan C, Bronstein JM. Wilson Disease: An Overview and Approach to Management. Neurol Clin. 2020;38:417-432. [PMID: 32279718 DOI: 10.1016/j.ncl.2020.01.005] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 7.5] [Reference Citation Analysis]
8 Członkowska A, Rodo M, Wierzchowska-Ciok A, Smolinski L, Litwin T. Accuracy of the radioactive copper incorporation test in the diagnosis of Wilson disease. Liver Int 2018;38:1860-6. [PMID: 29418065 DOI: 10.1111/liv.13715] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mazi TA, Shibata NM, Medici V. Lipid and energy metabolism in Wilson disease. Liver Res 2020;4:5-14. [PMID: 32832193 DOI: 10.1016/j.livres.2020.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
10 Mohr I, Weiss KH. Biochemical Markers for the Diagnosis and Monitoring of Wilson Disease. Clin Biochem Rev 2019;40:59-77. [PMID: 31205375 DOI: 10.33176/AACB-18-00014] [Cited by in Crossref: 20] [Cited by in F6Publishing: 4] [Article Influence: 6.7] [Reference Citation Analysis]
11 Theotoki EI, Velentzas AD, Katarachia SA, Papandreou NC, Kalavros NI, Pasadaki SN, Giannopoulou AF, Giannios P, Iconomidou VA, Konstantakou EG, Anastasiadou E, Papassideri IS, Stravopodis DJ. Targeting of copper-trafficking chaperones causes gene-specific systemic pathology in Drosophila melanogaster: prospective expansion of mutational landscapes that regulate tumor resistance to cisplatin. Biol Open 2019;8:bio046961. [PMID: 31575544 DOI: 10.1242/bio.046961] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]